TIDMIDHC

RNS Number : 0923S

Integrated Diagnostics Holdings PLC

07 March 2019

Integrated Diagnostics Holdings Plc

Company Announcement

7 March 2019

Appointment of J.P. Morgan Cazenove as Corporate Broker

(Cairo and London) - Integrated Diagnostics Holdings ("IDH" or "the Company"), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, announced today that it has appointed J.P. Morgan Cazenove as Corporate Broker.

-Ends-

About Integrated Diagnostics Holdings

IDH is a leading consumer healthcare company in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The Group's core brands include Al Borg and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan (both in Sudan) and Echo-Scan (Nigeria). A long track record for quality and safety has earned the Company a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 1,400 diagnostics tests. From its base of 405 branches as of 30 June 2018, IDH will continue to add laboratories through a Hub, Spoke and Spike business model that provides a scalable platform for efficient expansion. Beyond organic growth, the Group's expansion plans include acquisitions in new Middle Eastern and African markets where its model is well-suited to capitalise on similar healthcare and consumer trends and capture a significant share of fragmented markets. IDH has been a Jersey-registered entity with a Standard Listing on the Main Market of the London Stock Exchange (ticker: IDHC) since May 2015.

IDH's forward-looking strategy rests on leveraging its established business model to achieve four key strategic goals, namely: (1) continue to expand customer reach; (2) increase the number of tests per patient; (3) expand into new geographic markets through selective, value-accretive acquisitions; and (4) introduce new medical services by leveraging the Group's network and reputable brand position. Learn more at idhcorp.com.

Contacts

 
IDH                                      +20 (0)2 3345 5530 
Sherif El-Ghamrawi, Investor Relations   +20 (0)10 0447 8699 
 Director                                 sherif.elghamrawi@idhcorp.com 
 
Hudson Sandler (International Media 
 relations)                              +44 (0) 207 796 4133 
Dan de Belder                            idh@hudsonsandler.com 
 Bertie Berger

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

APPSSDFWMFUSEDD

(END) Dow Jones Newswires

March 07, 2019 02:02 ET (07:02 GMT)

Integrated Diagnostics (LSE:IDHC)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Integrated Diagnostics Charts.
Integrated Diagnostics (LSE:IDHC)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Integrated Diagnostics Charts.